Myriad Genetics Inc
NASDAQ:MYGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Myriad Genetics Inc
NASDAQ:MYGN
|
US |
|
W
|
Webus International Ltd
NASDAQ:WETO
|
CN |
|
J
|
Johnson & Johnson
XMUN:JNJ
|
US |
|
I
|
Infineon Technologies AG
SWB:IFXA
|
DE |
|
Singapore Technologies Engineering Ltd
SGX:S63
|
SG |
|
H
|
Hasbro Inc
SWB:HAS
|
US |
|
F
|
Fidelity National Information Services Inc
DUS:ZGY
|
US |
|
S
|
Schoeller Bleckmann Oilfield Equipment AG
XHAM:SLL
|
AT |
|
Stingray Group Inc
TSX:RAY.A
|
CA |
|
L
|
Lennar Corp
NYSE:LEN.B
|
US |
|
O
|
Oculis Holding AG
SWB:CR5
|
CH |
|
Green Dot Corp
LSE:0J0N
|
US |
|
Malayan Banking Bhd
OTC:MLYNF
|
MY |
Wall St Price Targets
MYGN Price Targets Summary
Myriad Genetics Inc
According to Wall Street analysts, the average 1-year price target for MYGN is 6.63 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYGN's stock price target?
Price Target
6.63
USD
According to Wall Street analysts, the average 1-year price target for MYGN is 6.63 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Myriad Genetics Inc?
Projected CAGR
6%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 6%.
